Take the Lead: Forward a New Evolution in Slide-Free Pathology with MUSE Microscopy’s Groundbreaking SmartPath Technology

/EIN News/ -- IRVINE, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- MUSE Microscopy, Inc., a pioneer in digital pathology innovation, is proud to announce the development of its revolutionary slide-free, digital tissue imaging platform. This cutting-edge technology is set to redefine traditional histology workflows by enabling the generation of high-quality digital tissue images in minutes—at a fraction of the time required for conventional FFPE slide processing. With this advancement, pathologists have the potential to rapidly access images to reduce the total turnaround time.

Join Us for an Exclusive Presentation and Panel Discussion

MUSE Microscopy invites you to an enlightening evening on Monday, March 24, from 5:30 PM to 7:00 PM Eastern Time, where industry leaders will unveil the future of digital pathology. Esteemed presenters and panelists include Dr. Richard Levenson, Dr. Jianyu Rao, Dr. Hong Zou, Dr. Jeffrey Edwards, and MUSE CEO Matthew Nuñez, in addition to other leading industry experts, will share their expertise on the transformative potential of slide-free pathology. The event will culminate in a dynamic panel discussion moderated by Dr. Aleksandra Żuraw of Digital Pathology Place, offering a deep dive into the implications of this novel technology.

Discover SmartPath MUSE Technology: A Leap Forward in Pathology Efficiency

At the heart of this innovation is SmartPath MUSE Technology™ (SmartPath), a state-of-the-art platform designed to streamline pathology workflows and eliminate the need for traditional glass slides. The goal of SmartPath is to enable pathologists to review images much sooner than traditional methods by digitizing images directly from tissue, paving the way for a new era in diagnostic medicine.

Why Attend?

• Gain Insights: Learn how slide-free pathology may revolutionize histology workflows and improve the overall timeline to render diagnosis for patients.
• Network: Connect with leading experts and peers in the field of digital pathology.
• Experience Innovation: Witness live demonstrations of SmartPath and explore its potential to transform your practice.
  

Event Details

• Date: Monday, March 24, 2025
• Time: 5:30 PM – 7:00 PM Eastern Time
• Location: USCAP25 Conference, Room 1
• Live Stream: Can’t attend in person? Register for the virtual Live Stream event.

Be Part of the Movement

MUSE Microscopy is committed to advancing the field of pathology through innovation and collaboration. We invite you to join us at USCAP25 to experience the future of digital pathology firsthand. Together, let’s take the lead in shaping a new evolution in healthcare innovation.

For more information about the USCAP25 event and to register, visit the official event website at https://2025am.uscap.org/. Don’t miss this opportunity to be at the forefront of change—stop by Booth #528 or tune in to our Live Stream to see how SmartPath is redefining what’s possible in pathology.

About MUSE Microscopy, Inc.

Muse Microscopy, Inc. is a company that specializes in the application of Microscopy with Ultraviolet Surface Excitation (MUSE). We have developed a MUSE-enabled imaging system for diagnostic assistance in pathology, cytology, and research applications. Our commercial product, SmartPath MUSE Technology™ (SmartPath)*, is a slide-free direct-to-digital imaging platform that aims to transform the patient’s experience and provide healthcare professionals with quick diagnostic information through digital imaging.

To learn more, you can visit their website at https://musemicroscopy.com/ or find them on social media platforms such as Twitter, Facebook, and LinkedIn. *Pending FDA approval.

Limits on Accuracy
This press release is intended to provide information about MUSE Microscopy, Inc.’s research and potential product. Information is believed to be accurate at the time it is created. However, like any printed material, information may become outdated over time. Information may contain technical inaccuracies or typographical errors. Information may be changed or updated without notice. There may also be improvements or changes in the products and services described in this press release at any time without notice. It is important that you rely on the advice of an appropriate professional. Nothing contained in any presentation is to be construed as medical, legal, investment, financial, or other advice. This information is not intended to be a substitute for such advice. MUSE Microscopy, Inc., does not endorse any specific techniques or methods of treatment. Individuals are advised to consult their health care professionals for full information about the potential adverse reactions from use of the medical technologies discussed in this press release. We will use reasonable efforts to include accurate and up-to-date information on the website, but MUSE Microscopy, Inc. makes no warranties or representations as to its accuracy.

Forward-Looking Statements 
Forward-looking statements in this press release are based on our future expectations, plans, prospects, and assumptions regarding matters that are not historical facts, may constitute “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. The words “termed,” “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. Therefore, we caution you against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. 

Any forward-looking statement made by us in this document speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as may be required by law. 

CONTACT:
Matthew Nuñez
Tel: 949.813.6121 
mnunez@musemicroscopy.com 

Source: MUSE Microscopy, Inc. 

Join the Evolution. Embrace the Future.

#DigitalPathology #SlideFreeRevolution #SmartPathMUSE #USCAP25